Alector to Participate at Virtual Investor Conferences in September
04 September 2020 - 6:05AM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology, today announced that members
of management will participate in fireside chats at the following
upcoming virtual investor conferences:
- Citi’s 15th Annual BioPharma Virtual Conference, Thursday,
September 10, 2020, at 11:40 a.m. ET
- Morgan Stanley 18th Annual Global Healthcare Conference,
Monday, September 14, 2020, at 12:00 p.m. ET
Live webcasts of each fireside chat will be available on the
“Events & Presentations” page within the Investors section of
the Alector website at http://investors.alector.com. Replays of the
webcasts will be available on the Alector website for 30 days
following the event.
About Alector
Alector is a clinical stage biotechnology company
pioneering immuno-neurology, a novel therapeutic approach for the
treatment of neurodegenerative diseases. Immuno-neurology targets
immune dysfunction as a root cause of multiple pathologies that are
drivers of degenerative brain disorders. Alector is
developing a broad portfolio of programs designed to functionally
repair genetic mutations that cause dysfunction of the brain’s
immune system and enable the rejuvenated immune cells to counteract
emerging brain pathologies. The Company’s product candidates are
supported by biomarkers and target genetically defined patient
populations in frontotemporal dementia and Alzheimer’s
disease. Alector is headquartered in South San
Francisco, California. For additional information, please
visit www.alector.com.
ContactsMedia:Erica JeffersonVice President,
Communications and Public AffairsAlector,
Inc.301-928-4650erica.jefferson@alector.com
1ABDan Budwick973-271-6085dan@1abmedia.com
or
Investors:Alector, Inc.ir@alector.com
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Apr 2024 to May 2024
Alector (NASDAQ:ALEC)
Historical Stock Chart
From May 2023 to May 2024